Abstract
Our purpose is to develop a clinical decision support system to classify the patients’ diagnostics based on features gathered from Magnetic Resonance Imaging (MRI) and Expanded Disability Status Scale (EDSS). We studied 120 patients and 19 healthy individuals (not afflicted with MS) have been studied for this study. Healthy individuals in the control group do not have any complaint or drug use history. For the kernel trick, efficient performance in non-linear classification, the Convex Combination of Infinite Kernels model was developed to measure the health status of patients based on features gathered from MRI and EDSS. Our calculations show that our proposed model classifies the multiple sclerosis (MS) diagnosis level with better accuracy than single kernel, artificial neural network and other machine learning methods, and it can also be used as a decision support system for identifying MS health status of patients.
Keywords: Clinical decision support, infinite kernel classification, multiple sclerosis, patient diagnostic.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels
Volume: 16 Issue: 1
Author(s): Yeliz Karaca, Yu-Dong Zhang, Carlo Cattani and Ugur Ayan
Affiliation:
Keywords: Clinical decision support, infinite kernel classification, multiple sclerosis, patient diagnostic.
Abstract: Our purpose is to develop a clinical decision support system to classify the patients’ diagnostics based on features gathered from Magnetic Resonance Imaging (MRI) and Expanded Disability Status Scale (EDSS). We studied 120 patients and 19 healthy individuals (not afflicted with MS) have been studied for this study. Healthy individuals in the control group do not have any complaint or drug use history. For the kernel trick, efficient performance in non-linear classification, the Convex Combination of Infinite Kernels model was developed to measure the health status of patients based on features gathered from MRI and EDSS. Our calculations show that our proposed model classifies the multiple sclerosis (MS) diagnosis level with better accuracy than single kernel, artificial neural network and other machine learning methods, and it can also be used as a decision support system for identifying MS health status of patients.
Export Options
About this article
Cite this article as:
Karaca Yeliz, Zhang Yu-Dong, Cattani Carlo and Ayan Ugur, The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels, CNS & Neurological Disorders - Drug Targets 2017; 16 (1) . https://dx.doi.org/10.2174/1871527315666161024142439
DOI https://dx.doi.org/10.2174/1871527315666161024142439 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications
Current Pharmaceutical Design Protease Inhibitors with Antileishmanial Activity
Current Enzyme Inhibition Critical Atomic-level Processing Technologies: Remote Plasma-enhanced Atomic Layer Deposition and Atomic Layer Etching
Micro and Nanosystems Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives
Anti-Cancer Agents in Medicinal Chemistry Prolactin Protects Against the Methamphetamine-Induced Cerebral Vascular Toxicity
Current Neurovascular Research RNAi Screening for the Discovery of Novel Modulators of Human Disease
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics’ (‘Spice’) Intake?
CNS & Neurological Disorders - Drug Targets Nano Approaches to Enhance Pharmacokinetic and Pharmacodynamic Activity of Plant Origin Drugs
Current Nanoscience Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors
Current Diabetes Reviews Serum Insulin Degrading Enzyme Level and Other Factors in Type 2 Diabetic Patients with Mild Cognitive Impairment
Current Alzheimer Research Effects of Cannabis on the Adolescent Brain
Current Pharmaceutical Design Carotid Arterial Stiffness and Cerebral Blood Flow in Amnestic Mild Cognitive Impairment
Current Alzheimer Research Infectious Complications with Anti-TNFα Therapy in Rheumatic Diseases: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Preventing Child and Adolescent Mental Illness - We Got This
Adolescent Psychiatry The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) Targeting the Cell Cycle in the Pursuit of Novel Chemotherapies Against Parasitic Protozoa
Current Pharmaceutical Design PET Studies of Brain Monoamine Transporters
Current Pharmaceutical Design Accumulation of Intraneuronal Amyloid-β is Common in Normal Brain
Current Alzheimer Research Monitoring Drug Use Among HIV/AIDS Patients in Brazil: Should we Combine Self-Report and Urinalysis?
Current HIV Research